NextCure Inc (NASDAQ:NXTC)
| 12.21 Delayed Data As of Jan 19 |  -0.10 / -0.81%Today’s Change | 7.91 Today|||52-Week Range 51.33 | +12.02% Year-to-Date |
Latest NXTC News | Press Releases
No recent news for NextCure Inc.
Today’s Trading
| Previous close | 12.31 |
| Today’s open | 12.35 |
| Day’s range | 11.93 - 12.38 |
| Volume | 9,948 |
| Average volume (3 months) | 402,744 |
| Market cap | $338.9M |
Data as of 4:00pm ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | -114.16% |
| Earnings growth (this year) | +37.73% |
| Earnings growth (next 5 years) | -19.12% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 139.30 |
| Price/Book | 1.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INMBINmune Bio Inc | +1.87 | +7.53% |
| VTGNVistaGen Therapeutic... | -0.06 | -2.71% |
| CBMGCellular Biomedicine... | +0.01 | +0.06% |
| LCTXLineage Cell Therape... | +0.30 | +13.82% |
Data as of 3:59pm ET, 01/19/2021
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $6.3M |
| Annual profit (last year) | -$33.7M |
| Net profit margin | -531.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beltsville, Maryland |
Forecasts
